Massive study aims to beat deadly fungus in transplant patients
NCT ID NCT07569055
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks 6000 stem cell transplant patients over 5 years to understand serious fungal infections. Researchers will collect data on diagnosis, treatment, and survival to create better prevention and care guidelines. The goal is to improve long-term outcomes for transplant recipients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test outsmart deadly fungal infections in blood cancer?
- New antifungal drug shows promise against deadly fungal infections
- New hope for blood cancer patients with tough fungal infections
- New study aims to spot lung trouble before it starts in transplant patients
- New drug duo aims to slash leukemia relapse after bone marrow transplant
- New drug could shield transplant patients from deadly fungal infections